{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:22:01Z","timestamp":1794057721087,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non\u2011alcoholic fatty liver disease (NAFLD) is characterized by excessive hepatic fat accumulation and is closely associated with inflammation and metabolic dysregulation. The C\u2011reactive protein\u2013albumin\u2013lymphocyte (CALLY) index, a composite marker of inflammation, immunity, and nutritional status, remains understudied in relation to NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A crosssectional analysis was conducted using data from 7,271 U.S. adults in NHANES 2017\u20132020. NAFLD was defined by vibrationcontrolled transient elastography with a controlled attenuation parameter (CAP)\u2009&gt;\u2009274 dB\/m. Weighted logistic regression, restricted cubic spline (RCS) modeling, and twopiecewise logistic regression were applied to assess linear and nonlinear associations between the CALLY index and NAFLD prevalence. Subgroup and sensitivity analyses were performed to evaluate the consistency and robustness of the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean CALLY index was 8.08 (SD 12.42). Higher CALLY levels were inversely associated with NAFLD prevalence ( OR \u2009=\u20090.96; 95% CI, 0.95\u20130.98). Compared with the lowest quartile (Q1\u2009&lt;\u20091.90), the highest quartile (Q4\u2009&gt;\u200910.00) showed a 61% lower prevalence of NAFLD (OR\u2009=\u20090.39; 95% CI, 0.24\u20130.64). RCS analysis demonstrated a significant nonlinear relationship, with a threshold at 8.91; below this value, each unit increase in the CALLY index corresponded to a 10% reduction in NAFLD prevalence (OR\u2009=\u20090.90; 95% CI, 0.88\u20130.92). Subgroup and sensitivity analyses yielded consistent results, confirming the robustness of these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The CALLY index demonstrates a significant inverse association with NAFLD prevalence and may serve as a simple composite indicator for identifying individuals at higher likelihood of NAFLD, providing additional insights to inform future screening and risk\u2011stratification research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-025-01926-y","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T06:58:15Z","timestamp":1756450695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of CALLY index with NAFLD in U.S. adults from NHANES 2017\u20132020 assessed by vibration-controlled transient elastography"],"prefix":"10.1186","volume":"17","author":[{"given":"Xunge","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"1926_CR1","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA, Krag A. Steatotic liver disease. Lancet (London England). 2024;404:1761\u201378.","journal-title":"Lancet (London England)"},{"key":"1926_CR2","doi-asserted-by":"publisher","first-page":"962834","DOI":"10.3389\/fnut.2022.962834","volume":"9","author":"Z Keshavarz","year":"2022","unstructured":"Keshavarz Z, Rahimlou M, Farjam M, Homayounfar R, Khodadost M, Abdollahi A, et al. Non-alcoholic fatty liver disease and dairy products consumption: results from FASA Persian cohort study. Front Nutr. 2022;9:962834.","journal-title":"Front Nutr"},{"key":"1926_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/1747-0080.12543","volume":"77","author":"R Hashemi","year":"2020","unstructured":"Hashemi R, Mehdizadeh Khalifani A, Rahimlou M, Manafi M. Comparison of the effect of dietary approaches to stop hypertension diet and American diabetes association nutrition guidelines on lipid profiles in patients with type 2 diabetes: A comparative clinical trial. Nutr Dietetics: J Dietitians Association Australia. 2020;77:204\u201311.","journal-title":"Nutr Dietetics: J Dietitians Association Australia"},{"key":"1926_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40200-020-00536-x","volume":"19","author":"M Morvaridi","year":"2020","unstructured":"Morvaridi M, Rayyani E, Jaafari M, Khiabani A, Rahimlou M. The effect of green coffee extract supplementation on cardio metabolic risk factors: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord. 2020;19:645\u201360.","journal-title":"J Diabetes Metab Disord"},{"key":"1926_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158:1851\u201364.","journal-title":"Gastroenterology"},{"key":"1926_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","volume":"73","author":"Y Saiman","year":"2022","unstructured":"Saiman Y, Duarte-Rojo A, Rinella ME. Fatty liver disease: diagnosis and stratification. Annu Rev Med. 2022;73:529\u201344.","journal-title":"Annu Rev Med"},{"key":"1926_CR7","doi-asserted-by":"publisher","first-page":"e232475","DOI":"10.1148\/radiol.232475","volume":"309","author":"A Han","year":"2023","unstructured":"Han A. Hepatic steatosis assessment: Harnessing the power of integrating multiple quantitative US parameters. Radiology. 2023;309:e232475.","journal-title":"Radiology"},{"key":"1926_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22:429\u201343.","journal-title":"Nat Rev Immunol"},{"key":"1926_CR9","doi-asserted-by":"publisher","first-page":"e70091","DOI":"10.1111\/liv.70091","volume":"45","author":"A Ramandi","year":"2025","unstructured":"Ramandi A, Diehl AM, Sanyal AJ, de Jong YP. Experimental models to investigate PNPLA3 in liver steatosis. Liver International: Official J Int Association Study Liver. 2025;45:e70091.","journal-title":"Liver International: Official J Int Association Study Liver"},{"key":"1926_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10238-022-00799-z","volume":"23","author":"AB Chowdhury","year":"2023","unstructured":"Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Experimental Med. 2023;23:273\u201385.","journal-title":"Clin Experimental Med"},{"key":"1926_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/gutjnl-2022-327498","volume":"72","author":"G Angelini","year":"2023","unstructured":"Angelini G, Panunzi S, Castagneto-Gissey L, Pellican\u00f2 F, De Gaetano A, Pompili M, et al. Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis. Gut. 2023;72:392\u2013403.","journal-title":"Gut"},{"key":"1926_CR12","doi-asserted-by":"crossref","unstructured":"Androutsakos T, Dimitriadis K, Revenas K, Vergadis C, Papadakis DD, Sakellariou S et al. Liver biopsy: to do or not to do - A Single-Center study. Digestive diseases (Basel, Switzerland). 2023;41:913\u201321.","DOI":"10.1159\/000533328"},{"key":"1926_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3350\/cmh.2020.0081","volume":"26","author":"TS Lim","year":"2020","unstructured":"Lim TS, Kim JK. Is liver biopsy still useful in the era of non-invasive tests? Clin Mol Hepatol. 2020;26:302\u20134.","journal-title":"Clin Mol Hepatol"},{"key":"1926_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1148\/radiol.221177","volume":"305","author":"TJ Dubinsky","year":"2022","unstructured":"Dubinsky TJ. Evaluating hepatic steatosis with MRI as the reference standard: different performances of three US machines. Radiology. 2022;305:362\u20133.","journal-title":"Radiology"},{"key":"1926_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Reviews Endocrinol. 2022;18:55\u201366.","journal-title":"Nat Reviews Endocrinol"},{"key":"1926_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40261-022-01141-x","volume":"42","author":"R de la Aller","year":"2022","unstructured":"de la Aller R. Nutrition and chronic liver disease. Clin Drug Investig. 2022;42:55\u201361.","journal-title":"Clin Drug Investig"},{"key":"1926_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Reviews Gastroenterol Hepatol. 2023;20:633\u201346.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"1926_CR18","doi-asserted-by":"publisher","first-page":"goad059","DOI":"10.1093\/gastro\/goad059","volume":"11","author":"AP Okekunle","year":"2023","unstructured":"Okekunle AP, Youn J, Song S, Chung GE, Yang SY, Kim YS, et al. Predicted pro-inflammatory hs-CRP score and non-alcoholic fatty liver disease. Gastroenterol Rep. 2023;11:goad059.","journal-title":"Gastroenterol Rep"},{"key":"1926_CR19","doi-asserted-by":"publisher","first-page":"112860","DOI":"10.1016\/j.intimp.2024.112860","volume":"141","author":"H Ji","year":"2024","unstructured":"Ji H, Luo Z, Ye L, He Y, Hao M, Yang Y, et al. Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Int Immunopharmacol. 2024;141:112860.","journal-title":"Int Immunopharmacol"},{"key":"1926_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.clnesp.2024.06.054","volume":"63","author":"L Luo","year":"2024","unstructured":"Luo L, Li M, Xi Y, Hu J, Hu W. C-reactive protein-albumin-lymphocyte index as a feasible nutrition-immunity-inflammation marker of the outcome of all-cause and cardiovascular mortality in elderly. Clin Nutr ESPEN. 2024;63:346\u201353.","journal-title":"Clin Nutr ESPEN"},{"key":"1926_CR21","doi-asserted-by":"publisher","first-page":"24591","DOI":"10.1038\/s41598-024-75164-z","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Wei Q, Ke X, Xu Y, Xu B, Zhang K, et al. Higher CALLY index levels indicate lower sarcopenia risk among middle-aged and elderly community residents as well as hospitalized patients. Sci Rep. 2024;14:24591.","journal-title":"Sci Rep"},{"key":"1926_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/COPD.S485036","volume":"20","author":"Y Ding","year":"2025","unstructured":"Ding Y, Liu Y, Yu J, Cai C, Fu L, Zhu J, et al. The association between the CALLY index and All-Cause mortality in patients with COPD: results from the cohort study of NHANES 2007\u20132010. Int J Chronic Obstr Pulm Dis. 2025;20:159\u201369.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"1926_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13098-025-01609-8","volume":"17","author":"L Wu","year":"2025","unstructured":"Wu L, Han D, Xue Y, He S, Ma Z, Su S, et al. Association between the C-reactive protein-albumin-lymphocyte index and metabolic syndrome: evidence from the 2003\u20132010 National health and nutrition examination survey. Diabetol Metab Syndr. 2025;17:39.","journal-title":"Diabetol Metab Syndr"},{"key":"1926_CR24","first-page":"533","volume":"31","author":"XY Liu","year":"2023","unstructured":"Liu XY, Zhang X, Zhang Q, Ruan GT, Liu T, Xie HL, et al. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer. Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer. 2023;31:533.","journal-title":"Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer"},{"key":"1926_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.hpb.2021.06.414","volume":"24","author":"H Iida","year":"2022","unstructured":"Iida H, Tani M, Komeda K, Nomi T, Matsushima H, Tanaka S, et al. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma. HPB: Official J Int Hepato Pancreato Biliary Association. 2022;24:101\u201315.","journal-title":"HPB: Official J Int Hepato Pancreato Biliary Association"},{"key":"1926_CR26","first-page":"112191","volume":"116","author":"H Zhang","year":"2023","unstructured":"Zhang H, Shi J, Xie H, Liu X, Ruan G, Lin S, et al. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer. Nutrition (Burbank, Los Angeles County. Calif). 2023;116:112191.","journal-title":"Calif)"},{"key":"1926_CR27","doi-asserted-by":"crossref","unstructured":"Petrescu M, Vlaicu SI, Cium\u0103rnean L, Milaciu MV, M\u0103rginean C, Florea M et al. Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue. Medicina (Kaunas, Lithuania). 2022;58.","DOI":"10.3390\/medicina58050641"},{"key":"1926_CR28","doi-asserted-by":"publisher","first-page":"e37197","DOI":"10.1016\/j.heliyon.2024.e37197","volume":"10","author":"Z Xu","year":"2024","unstructured":"Xu Z, Tang J, Xin C, Jin Y, Zhang H, Liang R. Associations of C-reactive protein-albumin-lymphocyte (CALLY) index with cardiorenal syndrome: insights from a population-based study. Heliyon. 2024;10:e37197.","journal-title":"Heliyon"},{"key":"1926_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12872-025-04544-8","volume":"25","author":"J Ye","year":"2025","unstructured":"Ye J, Chen L, Xu D, Li R, Lan R, Chen S, et al. Inverse association between CALLY index and angina pectoris in US adults: a population-based study. BMC Cardiovasc Disord. 2025;25:94.","journal-title":"BMC Cardiovasc Disord"},{"key":"1926_CR30","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1186\/s12885-024-13261-y","volume":"24","author":"D Zhu","year":"2024","unstructured":"Zhu D, Lin YD, Yao YZ, Qi XJ, Qian K, Lin LZ. Negative association of C-reactive protein-albumin-lymphocyte index (CALLY index) with all-cause and cause-specific mortality in patients with cancer: results from NHANES 1999\u20132018. BMC Cancer. 2024;24:1499.","journal-title":"BMC Cancer"},{"key":"1926_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12944-023-01861-9","volume":"22","author":"CF Lu","year":"2023","unstructured":"Lu CF, Cang XM, Liu WS, Wang LH, Huang HY, Sang SM, et al. Association between the platelet\/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017\u20132020. Lipids Health Dis. 2023;22:130.","journal-title":"Lipids Health Dis"},{"key":"1926_CR32","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of fibroscan controlled Attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1717\u201330.","journal-title":"Gastroenterology"},{"key":"1926_CR33","doi-asserted-by":"publisher","first-page":"857110","DOI":"10.3389\/fendo.2022.857110","volume":"13","author":"R Xie","year":"2022","unstructured":"Xie R, Liu M. Relationship between Non-Alcoholic fatty liver disease and degree of hepatic steatosis and bone mineral density. Front Endocrinol. 2022;13:857110.","journal-title":"Front Endocrinol"},{"key":"1926_CR34","doi-asserted-by":"publisher","first-page":"e2519236","DOI":"10.1001\/jamanetworkopen.2025.19236","volume":"8","author":"C Le Cornet","year":"2025","unstructured":"Le Cornet C, Jung AY, Behrens S, Middha P, Truong T, Jernstr\u00f6m H, et al. Exogenous hormones, tumor intrinsic subtypes, and breast cancer. JAMA Netw Open. 2025;8:e2519236.","journal-title":"JAMA Netw Open"},{"key":"1926_CR35","doi-asserted-by":"publisher","first-page":"1438639","DOI":"10.3389\/fendo.2025.1438639","volume":"16","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Mou Y, Wu P, Wang K, Chen T, Chen Z, et al. Association between magnesium depletion score and prevalence of hyperuricemia in American adults: a study based on NHANES 2007\u20132018. Front Endocrinol. 2025;16:1438639.","journal-title":"Front Endocrinol"},{"key":"1926_CR36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1186\/s12891-024-07984-z","volume":"25","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Pan H, Huang R, Wu P, Peng C, Luo J, et al. Association of hemoglobin-to-red blood cell distribution width ratio and bone mineral density in older adults. BMC Musculoskelet Disord. 2024;25:866.","journal-title":"BMC Musculoskelet Disord"},{"key":"1926_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/07853890.2019.1693056","volume":"51","author":"L Sun","year":"2019","unstructured":"Sun L, Yin H, Liu M, Xu G, Zhou X, Ge P, et al. Impaired albumin function: a novel potential indicator for liver function damage? Ann Med. 2019;51:333\u201344.","journal-title":"Ann Med"},{"key":"1926_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12920-024-01879-7","volume":"17","author":"N Zhu","year":"2024","unstructured":"Zhu N, Wang X, Zhu H, Zheng Y. Blood cell parameters and risk of nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study. BMC Med Genom. 2024;17:102.","journal-title":"BMC Med Genom"},{"issue":"Suppl 1","key":"1926_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/liv.14360","volume":"40","author":"G Bern\u00e1","year":"2020","unstructured":"Bern\u00e1 G, Romero-Gomez M. The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management. Liver International: Official J Int Association Study Liver. 2020;40(Suppl 1):102\u20138.","journal-title":"Liver International: Official J Int Association Study Liver"},{"key":"1926_CR40","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.clinthera.2022.04.012","volume":"44","author":"ND Shah","year":"2022","unstructured":"Shah ND, Barritt AS. Nutrition as therapy in liver disease. Clin Ther. 2022;44:682\u201396.","journal-title":"Clin Ther"},{"key":"1926_CR41","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcmgh.2022.01.007","volume":"13","author":"RGR Mooli","year":"2022","unstructured":"Mooli RGR, Ramakrishnan SK. Liver steatosis is a driving factor of inflammation. Cell Mol Gastroenterol Hepatol. 2022;13:1267\u201370.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1926_CR42","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese M, Cabrera D, Kalergis AM, Feldstein AE. Innate immunity and inflammation in NAFLD\/NASH. Dig Dis Sci. 2016;61:1294\u2013303.","journal-title":"Dig Dis Sci"},{"key":"1926_CR43","doi-asserted-by":"crossref","unstructured":"Eckart A, Struja T, Kutz A, Baumgartner A, Baumgartner T, Zurfluh S et al. Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: A prospective study. Am J Med. 2020;133:713\u2009\u2013\u200922.e7.","DOI":"10.1016\/j.amjmed.2019.10.031"},{"key":"1926_CR44","doi-asserted-by":"crossref","unstructured":"Belinskaia DA, Voronina PA, Shmurak VI, Jenkins RO, Goncharov NV. Serum albumin in health and disease: esterase, antioxidant, transporting and signaling properties. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms221910318"},{"key":"1926_CR45","doi-asserted-by":"crossref","unstructured":"Wu N, Liu T, Tian M, Liu C, Ma S, Cao H et al. Albumin, an interesting and functionally diverse protein, varies from \u2018native\u2019 to \u2018effective\u2019 (Review). Mol Med Rep. 2024;29.","DOI":"10.3892\/mmr.2023.13147"},{"key":"1926_CR46","doi-asserted-by":"crossref","unstructured":"Ficht X, Iannacone M. Immune surveillance of the liver by T cells. Sci Immunol. 2020;5.","DOI":"10.1126\/sciimmunol.aba2351"},{"key":"1926_CR47","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","volume":"3","author":"H Tilg","year":"2021","unstructured":"Tilg H, Adolph TE, Dudek M, Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metabolism. 2021;3:1596\u2013607.","journal-title":"Nat Metabolism"},{"key":"1926_CR48","doi-asserted-by":"crossref","unstructured":"Plebani P M. Why C-reactive protein is one of the most requested tests in clinical laboratories? Clin Chem Lab Med. 2023;61:1540\u20135.","DOI":"10.1515\/cclm-2023-0086"},{"key":"1926_CR49","doi-asserted-by":"publisher","first-page":"1237729","DOI":"10.3389\/fimmu.2023.1237729","volume":"14","author":"SA Rizo-T\u00e9llez","year":"2023","unstructured":"Rizo-T\u00e9llez SA, Sekheri M, Filep JG. C-reactive protein: a target for therapy to reduce inflammation. Front Immunol. 2023;14:1237729.","journal-title":"Front Immunol"},{"key":"1926_CR50","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","volume":"13","author":"Y Duan","year":"2022","unstructured":"Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman PL, et al. Association of inflammatory cytokines with Non-Alcoholic fatty liver disease. Front Immunol. 2022;13:880298.","journal-title":"Front Immunol"},{"key":"1926_CR51","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s12672-025-02780-0","volume":"16","author":"MA Habibi","year":"2025","unstructured":"Habibi MA, Rashidi F, Delbari P, Hajikarimloo B, Hojjat SH, Kazemivand S, et al. The effect of radiotherapy on patients with EGFR-driven lung cancer brain metastasis: a systematic review and meta-analysis. Discover Oncol. 2025;16:1023.","journal-title":"Discover Oncol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01926-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:42:09Z","timestamp":1757454129000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01926-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01926-y","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Center for Health Statistics Research Ethics Review Board approved the study plan. Each participant completed a document acknowledging they understood the study. Secondary studies used a de-identified, publically available dataset and did not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}